USF1 and fatty liver disease: Studies have shown that in mice, inactivation of Usf1 significantly improves diet-induced dyslipidemia, obesity, IR, hepatic steatosis, and atherosclerosis (31), while NASH is associated with IR and increased expression of PPARγ in the liver (32).